Tags : Novo

Evotec and Novo Nordisk forms collaboration to develop novel small

Shots: The partnership will focus on indications like diabetes, obesity, co morbidities including nonalcoholic steatohepatitis (NASH), cardiovascular diseases, and diabetic kidney disease Evotec’s drug-discovery platform will be used in ligand-based design to produce products for patients Also the Evotec’s INDiGO platform will be used by Novo, to perform IND registration through pre-clinical studies. Financial details […]Read More